Dr. Reddy’s Laboratories Ltd ADR Cash Flow Reinvestment Rate

Latest as of December 2025: 0.99x

Dr. Reddy’s Laboratories Ltd ADR cash flow reinvestment rate. Dr. Reddy’s Laboratories Ltd ADR (RDY) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting $10.80 Billion (capex $7.32 Billion plus investments $-3.48 Billion) from operating cash flow of $10.91 Billion. See financial agility of Dr. Reddy’s Laboratories Ltd ADR to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.99x
(Capex + Investments) / Operating CF

Total Reinvested

$10.80 Billion
Capex + Investments

Operating Cash Flow

$10.91 Billion
USD

Capital Expenditures

$7.32 Billion
USD

Cash Flow Reinvestment Rate of Dr. Reddy’s Laboratories Ltd ADR (2000–2025)

Cash flow reinvestment rate of Dr. Reddy’s Laboratories Ltd ADR from 2000 to 2025. Historical reinvestment intensity for Dr. Reddy’s Laboratories Ltd ADR across 26 annual periods. Explore Dr. Reddy’s Laboratories Ltd ADR debt service capacity to assess how comfortably operating cash covers total debt obligations.

Dr. Reddy’s Laboratories Ltd ADR Cash Flow Reinvestment Rate by Year (2000–2025)

Dr. Reddy’s Laboratories Ltd ADR cash flow reinvestment rate by year from 2000 to 2025. Year-by-year capital reinvestment analysis for Dr. Reddy’s Laboratories Ltd ADR. For the full cash flow conversion analysis, see Dr. Reddy’s Laboratories Ltd ADR (RDY) cash conversion ratio.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 1.99x $92.47 Billion $46.43 Billion $34.40 Billion ▲ +33.6%
2024 1.49x $67.72 Billion $45.43 Billion $27.43 Billion ▲ +45.7%
2023 1.02x $60.23 Billion $58.87 Billion $18.86 Billion ▼ -4.9%
2022 1.08x $30.25 Billion $28.11 Billion $19.05 Billion ▲ +130.5%
2021 0.47x $16.67 Billion $35.70 Billion $12.56 Billion ▲ +26.2%
2020 0.37x $11.04 Billion $29.84 Billion $6.12 Billion ▼ -30.2%
2019 0.53x $15.22 Billion $28.70 Billion $7.49 Billion ▼ -63.1%
2018 1.44x $25.93 Billion $18.03 Billion $11.04 Billion ▼ -48.0%
2017 2.76x $59.45 Billion $21.51 Billion $40.98 Billion ▲ +666.3%
2016 0.36x $14.88 Billion $41.25 Billion $14.88 Billion ▼ -41.1%
2015 0.61x $15.33 Billion $25.03 Billion $15.33 Billion ▼ -32.7%
2014 0.91x $17.72 Billion $19.46 Billion $10.63 Billion ▲ +65.2%
2013 0.55x $7.34 Billion $13.32 Billion $7.34 Billion ▲ +3.6%
2012 0.53x $8.59 Billion $16.15 Billion $8.59 Billion ▼ -63.3%
2011 1.45x $11.61 Billion $8.01 Billion $11.61 Billion ▲ +347.5%
2010 0.32x $4.28 Billion $13.23 Billion $4.28 Billion ▼ -69.4%
2009 1.06x $4.76 Billion $4.50 Billion $4.76 Billion ▼ -4.4%
2008 1.11x $6.77 Billion $6.12 Billion $6.77 Billion ▲ +175.6%
2007 0.40x $4.75 Billion $11.83 Billion $4.75 Billion ▼ -65.6%
2006 1.17x $1.92 Billion $1.65 Billion $1.92 Billion ▲ +52.7%
2005 0.76x $1.75 Billion $2.29 Billion $1.75 Billion ▲ +26.4%
2004 0.60x $2.42 Billion $4.01 Billion $2.42 Billion ▲ +74.0%
2003 0.35x $1.51 Billion $4.35 Billion $1.51 Billion ▲ +48.1%
2002 0.23x $1.09 Billion $4.65 Billion $1.09 Billion ▼ -70.4%
2001 0.79x $487.20 Million $614.87 Million $487.20 Million ▲ +97.8%
2000 0.40x $5.73 Million $14.29 Million $5.73 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow